India


India, Saudi Arabia signed five agreements to boost bilateral co-operation
India and Saudi Arabia inked five agreements to boost the bilateral cooperation between the two nations.
India seeks zero duty on textiles in FTA with Australia
India wants zero duty on textiles, automobile parts and fresh fruit. On its part, Australia is seeking tariff reduction in dairy products, fresh fruit, pharmaceuticals and wines.
India, EU fail to make headway on free trade agreement talks
India and EU have failed to made the much-awaited announcement on resumption of long stalled negotiations for a free trade agreement as many bottlenecks still remain.
India, Belgium pitch for resumption of Free Trade Agreement talks
India and Belgium pitched for resumption of the long stalled negotiations on the proposed India-EU free trade agreement (FTA) on "mutually agreed terms" as Prime Minister Modi and his counterpart Michel resolved to strengthen their bilateral ties.
Offers and counters ahead of RCEP talks
Hard bargaining between potential partners.
With RCEP commitment, India marks big shift in trade policy
New Delhi’s higher level of commitment on investment, services may become template for bilateral treaties
Businesses call for FTA reform as Indian exports continue to fall
Business leaders have called on the Indian government to conduct a thorough review of the country's trade agreements as experts predict this year’s exports will slump to 2010 levels.
Next round of RCEP negotiations in April in Australia
The next round of negotiations for the proposed mega trade deal, Regional Comprehensive Economic Partnership (RCEP), would take place in April in Australia.
India, China exchange tariff cut offers under RCEP
Plans to liberalise trade between India and China, the world's two fastest-growing large economies, have gathered momentum with both sides exchanging offers on removal of a chunk of tariff lines on goods imports.
US industry body says India agreed to not issue 'compulsory' drug licences
India has given private assurances that it will not grant licences allowing local firms to override patents and make cheap copies of drugs by big Western drugmakers.